Nucelocapsid Genoytpe 1A (AA 2-119) Peptide
Reactivité: Hepatitis C Virus (HCV)
Hôte: Escherichia coli (E. coli)
ELISA, WB
N° du produit ABIN935456
Aperçu rapide pour Nucelocapsid Genoytpe 1A (AA 2-119) Peptide (ABIN935456)
Antigène
Nucelocapsid Genoytpe 1A
Origine
Hepatitis C Virus (HCV)
Source
Escherichia coli (E. coli)
Application
ELISA, Western Blotting (WB)
-
-
Type de proteíne
- Recombinant
-
Protein Region
- AA 2-119
-
Attributs du produit
-
Hepatitis C Virus Core Genotype-1 a recombinant protein
Expression System: E.coli -
Purification
- Proprietary chromatographic technique
-
Pureté
- > 95 % pure
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 50 mM tris-HCl, pH 8.0, with 60 mM NaCl, 10 mM glutathione, 0.25 % sarkosil and 55 % glycerol.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- RT/-20 °C
-
-
- Nucelocapsid Genoytpe 1A
-
Classe de substances
- Viral Protein
-
Sujet
-
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Alternative Names: HCV protein, HCV Recombinant protein, Hep C protein, Hepatitis C protein, HCV Nucleocapsid Genoytpe 1A protein
Antigène
-
Vous êtes ici:
